Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Gemigliptin Add-on to Insulin in Type 2 Diabetes
NCT02831361Phase 3Completed
- Sponsor
- LG Chem
- Start
- Oct 2016
- Primary completion
- Feb 2018
- Modality
- Small Molecules
01
Overview
A Phase 3 trial of gemigliptin in type 2 diabetes mellitus (T2DM), sponsored by LG Chem. Started Oct 2016; status: completed.
02
Drugs
gemigliptin
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on NCT02831361.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02831361.